Guideline on the treatment of blood cholesterol: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) mNo edit summary |
Gerald Chi (talk | contribs) mNo edit summary |
||
| Line 4: | Line 4: | ||
==[[ACC AHA guideline on the treatment of blood cholesterol|ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce ASCV Risk in Adults]]== | ==[[ACC AHA guideline on the treatment of blood cholesterol|ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce ASCV Risk in Adults]]== | ||
[[ACC AHA guideline on the treatment of blood cholesterol statin treatment|Statin Treatment]] | [[ACC AHA guideline on the treatment of blood cholesterol intensity of statin therapy in primary and secondary prevention|Intensity of Statin Therapy]] | [[ACC AHA guideline on the treatment of blood cholesterol LDL and non-HDL treatment goals|LDL and Non-HDL Treatment Goals]] | [[ACC AHA guideline on the treatment of blood cholesterol primary prevention|Primary Prevention]] | [[ACC AHA guideline on the treatment of blood cholesterol secondary prevention|Secondary Prevention]] |[[ACC AHA guideline on the treatment of blood cholesterol heart failure and hemodialysis|Heart Failure and Hemodialysis]] | '''[[ACC AHA guideline on the treatment of blood cholesterol statin treatment|Statin Treatment]] | [[ACC AHA guideline on the treatment of blood cholesterol intensity of statin therapy in primary and secondary prevention|Intensity of Statin Therapy]] | [[ACC AHA guideline on the treatment of blood cholesterol LDL and non-HDL treatment goals|LDL and Non-HDL Treatment Goals]] | [[ACC AHA guideline on the treatment of blood cholesterol primary prevention|Primary Prevention]] | [[ACC AHA guideline on the treatment of blood cholesterol secondary prevention|Secondary Prevention]] | [[ACC AHA guideline on the treatment of blood cholesterol heart failure and hemodialysis|Heart Failure and Hemodialysis]]''' | ||
==[[ACC AHA guideline on the treatment of blood cholesterol safety|Safety]]== | ==[[ACC AHA guideline on the treatment of blood cholesterol safety|Safety]]== | ||
[[ACC AHA guideline on the treatment of blood cholesterol safety#Statin Safety Recommendations|Statin]] | [[ACC AHA guideline on the treatment of blood cholesterol safety#Nonstatin Safety Recommendations|Nonstatin]] | ''[[ACC AHA guideline on the treatment of blood cholesterol safety#Statin Safety Recommendations|Statin]] | [[ACC AHA guideline on the treatment of blood cholesterol safety#Nonstatin Safety Recommendations|Nonstatin]]''' | ||
==[[ACC AHA guideline on the treatment of blood cholesterol Managing Statin Therapy|Managing Statin Therapy]]== | ==[[ACC AHA guideline on the treatment of blood cholesterol Managing Statin Therapy|Managing Statin Therapy]]== | ||
[[ACC AHA guideline on the treatment of blood cholesterol Managing Statin Therapy#Monitoring Statin Therapy|Monitoring Statin Therapy]] | [[ACC AHA guideline on the treatment of blood cholesterol Managing Statin Therapy#Optimizing Statin Therapy|Optimizing statin therapy]] | [[ACC AHA guideline on the treatment of blood cholesterol Managing Statin Therapy#Insufficient Response to Statin Therapy|Insufficient Response]] | '''[[ACC AHA guideline on the treatment of blood cholesterol Managing Statin Therapy#Monitoring Statin Therapy|Monitoring Statin Therapy]] | [[ACC AHA guideline on the treatment of blood cholesterol Managing Statin Therapy#Optimizing Statin Therapy|Optimizing statin therapy]] | [[ACC AHA guideline on the treatment of blood cholesterol Managing Statin Therapy#Insufficient Response to Statin Therapy|Insufficient Response]]''' | ||
[[Category:Disease]] | [[Category:Disease]] | ||
Revision as of 23:53, 13 November 2013
Template:Hypercholesterolemia Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce ASCV Risk in Adults
Statin Treatment | Intensity of Statin Therapy | LDL and Non-HDL Treatment Goals | Primary Prevention | Secondary Prevention | Heart Failure and Hemodialysis
Safety
Managing Statin Therapy
Monitoring Statin Therapy | Optimizing statin therapy | Insufficient Response